Enzymatica AB Sweden

Enzymatica Interim report Q1/2024: MDR certification opens up great commercial opportunities

Stefan Olsson, Communication Manager, Enzymatica AB
Phone: [phone] | Email: [e-mail]

Enzymatica AB is headquartered in Lund, Sweden, and is listed on Nasdaq First North Growth Market.
For more information, please visit www.enzymatica.se. Enzymatica's Certified Adviser is Carnegie Investment Bank AB (publ).

This information was brought to you by Cision http://news.cision.com

https://news.cision.com/enzymatica-ab/r/interim-report-q1-2024--mdr-certification-opens-up-great-commercial-opportunities,c3967653

The following files are available for download:

https://mb.cision.com/Main/18091/3967653/2759265.pdf

The full report (PDF)

https://mb.cision.com/Public/18091/3967653/b2ca5530e5223012.pdf

Press release (PDF)

 

 

View original content:https://www.prnewswire.co.uk/news-releases/enzymatica-interim-report-q12024-mdr-certification-opens-up-great-commercial-opportunities-302127193.html